2008Zhongguo redai yixueRequires access

Distribution and drug resistance of Acinetobacter in 2005 to 2007.

Yan Zeng

Open publisher page 0 citations

Abstract

Objective.To investigate the distribution and drug resistance of Acinetobacter spp.in our hospital. Methods The drug resistacne of of Acinetobacter spp.isolated from 1 st January 2005 to31st December 2007 in our hospital was monitored. Results There 446 strains of Acinetobacter spp.were isolated including 395 strains of Acinetobacter baumannii(88.6%),29 strains of Acinetobacter lwoffii(6.5%).There 75.8% Acinetobacter spp were isolated from respiratory samples,4.3% from blood samples.The resistance rates of Acinetobacter spp to cefoperazone/sulbactam,imipenem,meropenem were all less than 20%. Conclusion Acinetobacter spp show low resistance to cefoperazone/sulbactam,imipenem,meropenem.But rational use of antibiotics is necessary for delay the development of drug reissitance.

About this research paper

What this paper is about

Objective.To investigate the distribution and drug resistance of Acinetobacter spp.in our hospital. Methods The drug resistacne of of Acinetobacter spp.isolated from 1 st January 2005 to31st December 2007 in our hospital was monitored. Results There 446 strains of Acinetobacter spp.were isolated including 395 strains of Acinetobacter baumannii(88.6%),29 strains of Acinetobacter lwoffii(6.5%).There 75.8% Acinetobacter spp were isolated from respiratory samples,4.3% from blood samples.The resistance rates of Acinetobacter spp to cefoperazone/sulbactam,imipenem,meropenem were all less than 20%. Conclusion Acinetobacter spp show low resistance to cefoperazone/sulbactam,imipenem,meropenem.But rational use of antibiotics is necessary for delay the development of drug reissitance.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective.To investigate the distribution and drug resistance of Acinetobacter spp.in our hospital. Methods The drug resistacne of of Acinetobacter spp.isolated from 1 st January 2005 to31st December 2007 in our hospital was monitored. Results There 446 strains of Acinetobacter spp.were isolated including 395 strains of Acinetobacter baumannii(88.6%),29 strains of Acinetobacter lwoffii(6.5%).There 75.8% Acinetobacter spp were isolated from respiratory samples,4.3% from blood samples.The resistance rates of Acinetobacter spp to cefoperazone/sulbactam,imipenem,meropenem were all less than 20%. Conclusion Acinetobacter spp show low resistance to cefoperazone/sulbactam,imipenem,meropenem.But rational use of antibiotics is necessary for delay the development of drug reissitance.

Key concepts: Meropenem, Acinetobacter, Cefoperazone, Sulbactam, Acinetobacter baumannii, Imipenem, Microbiology, Drug resistance

Related papers

Back to paper searchBrowse research topicsOriginal source
Distribution and drug resistance of Acinetobacter in 2005 to 2007. — Research Paper | ScholarLens